...
首页> 外文期刊>European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology >Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus
【24h】

Prognostic significance of tumor extension into venous system in patients undergoing surgical treatment for renal cell carcinoma with venous tumor thrombus

机译:肾细胞癌伴有静脉肿瘤血栓的手术治疗中肿瘤扩散到静脉系统的预后意义

获取原文
获取原文并翻译 | 示例
           

摘要

Aims: The objective of this study was to evaluate the prognostic significance of the extent of a tumor thrombus in renal cell carcinoma (RCC) involving the venous system. Methods: This study included 135 consecutive RCC patients with a venous tumor thrombus undergoing radical nephrectomy and tumor thrombectomy between 1985 and 2009. These patients were classified based on the maximal level of the tumor thrombus extending into the venous system, as follows: group 1, renal vein; group 2, infradiaphragmatic; and group 3, supradiaphragmatic. Results: Of the 135 patients, 65, 49 and 21 were classified into groups 1, 2 and 3, respectively. The 1, 3 and 5-year cancer-specific survival (CSS) rates in these 135 patients were 89.2, 56.9 and 49.2%, respectively. Among several factors examined, tumor size, tumor grade, perirenal fat invasion and presence of metastasis, but not extent of tumor thrombus, were significantly associated with CSS on univariate analysis. Of these significant factors, only tumor size and presence of metastasis appeared to be independently related to CSS on multivariate analysis. When the patients without metastasis were analyzed separately, CSS in groups 2 and 3 was significantly poorer than that in group 1. Conclusions: These findings suggest the absence of a significant prognostic impact of the level of the tumor thrombus in a complete cohort of RCC patients with a venous tumor thrombus; however, it is warranted to determine whether the level of the tumor thrombus has different effects on the prognosis according to the presence of metastatic diseases.
机译:目的:本研究的目的是评估肿瘤静脉血栓在涉及静脉系统的肾细胞癌(RCC)中的预后意义。方法:这项研究纳入了1985年至2009年间接受根治性肾切除术和肿瘤血栓切除术的135例连续的RCC静脉肿瘤血栓患者。根据这些患者伸入静脉系统的最大肿瘤血栓水平将其分类:第1组肾静脉第二组,in下;第三组,超语用。结果:在135例患者中,将65、49和21分为1、2和3组。这135名患者的1年,3年和5年癌症特异性存活率(CSS)分别为89.2%,56.9%和49.2%。在单因素分析中,检查的几个因素中,肿瘤大小,肿瘤等级,肾周脂肪浸润和转移的存在与肿瘤血栓的程度无关,而与肿瘤血栓的程度无关。在这些重要因素中,在多变量分析中,仅肿瘤大小和转移的出现似乎与CSS独立相关。分别分析无转移的患者时,第2组和第3组的CSS明显低于第1组。结论:这些发现表明,在完整的RCC组中,肿瘤血栓水平没有明显的预后影响有静脉肿瘤血栓;然而,根据转移性疾病的存在,有必要确定肿瘤血栓的水平对预后是否有不同的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号